Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Zippelius

Showing results (61-70 of 163) with videos related to

Pageof 17
Sort By:
Frontiers in Cell and Developmental Biology|March 21, 2022
Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in CancerJinyu Wang, Michela Manni, Anne Bärenwaldt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Four functionally distinct populations of human effector-memory CD8+ T lymphocytesPedro Romero, Alfred Zippelius, Isabel Kurth, et al.
Blood|May 17, 2003
Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functionsNathalie Rufer, Alfred Zippelius, Pascal Batard, et al.
Vaccine|December 13, 2002
Therapeutic cancer vaccines based on molecularly defined human tumor antigensPedro Romero, Mikael Pittet, Valerie Dutoit, et al.
Journal for Immunotherapy of Cancer|March 16, 2019
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunityAbhishek S Kashyap, Tamara Thelemann, Richard Klar, et al.
European Journal of Immunology|September 1, 2005
High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donorsSteffen Walter, Gilles Bioley, Hans-Jörg Bühring, et al.
Clinical Lung Cancer|May 29, 2012
Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08)Martin Früh, Richard Cathomas, Marco Siano, et al.
Frontiers in Immunology|November 6, 2023
<sup>13</sup>C tracer analysis reveals the landscape of metabolic checkpoints in human CD8<sup>+</sup> T cell differentiation and exhaustionAlexander Kirchmair, Niloofar Nemati, Giorgia Lamberti, et al.
Cellular & Molecular Immunology|March 6, 2024
Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2Ronja Wieboldt, Michael Sandholzer, Emanuele Carlini, et al.
Science Signaling|September 19, 2019
Tumor-derived TGF-β inhibits mitochondrial respiration to suppress IFN-γ production by human CD4<sup>+</sup> T cellsSarah Dimeloe, Patrick Gubser, Jordan Loeliger, et al.
Pageof 17

Showing results (61-70 of 163) with videos related to

Sort By:
Pageof 17
Frontiers in Cell and Developmental Biology|March 21, 2022
Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in CancerJinyu Wang, Michela Manni, Anne Bärenwaldt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Four functionally distinct populations of human effector-memory CD8+ T lymphocytesPedro Romero, Alfred Zippelius, Isabel Kurth, et al.
Blood|May 17, 2003
Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functionsNathalie Rufer, Alfred Zippelius, Pascal Batard, et al.
Vaccine|December 13, 2002
Therapeutic cancer vaccines based on molecularly defined human tumor antigensPedro Romero, Mikael Pittet, Valerie Dutoit, et al.
Journal for Immunotherapy of Cancer|March 16, 2019
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunityAbhishek S Kashyap, Tamara Thelemann, Richard Klar, et al.
European Journal of Immunology|September 1, 2005
High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donorsSteffen Walter, Gilles Bioley, Hans-Jörg Bühring, et al.
Clinical Lung Cancer|May 29, 2012
Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08)Martin Früh, Richard Cathomas, Marco Siano, et al.
Frontiers in Immunology|November 6, 2023
<sup>13</sup>C tracer analysis reveals the landscape of metabolic checkpoints in human CD8<sup>+</sup> T cell differentiation and exhaustionAlexander Kirchmair, Niloofar Nemati, Giorgia Lamberti, et al.
Cellular & Molecular Immunology|March 6, 2024
Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2Ronja Wieboldt, Michael Sandholzer, Emanuele Carlini, et al.
Science Signaling|September 19, 2019
Tumor-derived TGF-β inhibits mitochondrial respiration to suppress IFN-γ production by human CD4<sup>+</sup> T cellsSarah Dimeloe, Patrick Gubser, Jordan Loeliger, et al.
Pageof 17